Cannabinoid Formulations for Novel Applications

The present inventive concept extends the core technology of cannabinoid formulations to novel applications and use cases, including stress management in athletes, cognitive function enhancement in individuals with ADHD, anxiety treatment in pets, personalized skincare, and opioid dependence reduction in surgical patients.

The original patent disclosed cannabinoid formulations tailored to an individual's genotype. However, the patent's focus was limited to human medical conditions. The present inventive concept addresses the need for cannabinoid formulations in novel applications and use cases, where the benefits of cannabinoids can be leveraged to improve human and animal health, athletic performance, and skincare.

The inventive concept comprises a system and method for creating personalized cannabinoid formulations for novel applications and use cases. In the athletic performance application, the formulation is designed to optimize recovery and reduce inflammation based on the athlete's genotype and athletic performance data. In the ADHD application, the formulation is customized to enhance cognitive function based on the individual's genotype and cognitive profile. Similarly, the formulation for anxiety treatment in pets is tailored to the pet's breed, age, and anxiety level. The personalized skincare application involves a cannabinoid-based topical cream or serum formulated to address specific skin concerns based on an individual's genotype and skin type. Finally, the opioid dependence reduction application involves administering a customized cannabinoid formulation pre- and post-operatively to reduce pain and inflammation while minimizing opioid use.

The new claims introduce novel applications and use cases for cannabinoid formulations, which were not anticipated by the original patent. The inventive step lies in the extension of the core technology to these new areas, where the benefits of cannabinoids can be leveraged to create innovative solutions.

Alternative embodiments of the inventive concept may include different methods for collecting and analyzing genetic data, various formulations and delivery methods for the cannabinoids, and additional applications such as pain management, sleep disorders, or mental health.

The inventive concept has significant commercial potential in various industries, including sports medicine, mental health, veterinary care, skincare, and pain management. The market for cannabinoid-based products is growing rapidly, and the present inventive concept is poised to capture a significant share of this market.